Gusella, M., Pasini, F., Corso, B., Bertolaso, L., De Rosa, G., Falci, C., . . . Padrini, R. (2020). Predicting steady‐state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable? Pharmacol Res Perspect.
Stile di citazione ChicagoGusella, Milena, et al. "Predicting Steady‐state Endoxifen Plasma Concentrations in Breast Cancer Patients By CYP2D6 Genotyping or Phenotyping. Which Approach Is More Reliable?" Pharmacol Res Perspect 2020.
Citazione MLAGusella, Milena, et al. "Predicting Steady‐state Endoxifen Plasma Concentrations in Breast Cancer Patients By CYP2D6 Genotyping or Phenotyping. Which Approach Is More Reliable?" Pharmacol Res Perspect 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.